Presentation is loading. Please wait.

Presentation is loading. Please wait.

Specific Binding Characteristics of HLA Alleles Associated with Nevirapine Hypersensitivity Rebecca Pavlos, PhD The Institute for Immunology & Infectious.

Published byHilary Hall Modified over 8 years ago

Similar presentations

Presentation on theme: "Specific Binding Characteristics of HLA Alleles Associated with Nevirapine Hypersensitivity Rebecca Pavlos, PhD The Institute for Immunology & Infectious."— Presentation transcript:

1 Specific Binding Characteristics of HLA Alleles Associated with Nevirapine Hypersensitivity
Rebecca Pavlos, PhD The Institute for Immunology & Infectious Diseases, Murdoch University, Perth, Western Australia.

2 Nevirapine Non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 In triple combination therapy has been shown to suppress viral load Limited by Hypersensitivity in 5% of patients Risk is greater for women with pre-NVP CD4 count >250 cells/mm3 and men with pre-NVP CD4 count >400 cells/mm3.

3 Complex HLA associations
Ethnicity Phenotype Reference HLA-DRB1*01:01 (>25% CD4 T cells) West Australian, Caucasian Hepatic/systemic Martin et al, (2005); Yuan et al, (2011); Keane et al, (2014). HLA-DRB1*01:02 South African Heptatic Phillips et al, (2013). HLA-B*58:01 Hepatic HLA-B*35 Asian, Thai, Indian cADR Yuan et al, (2011); Umapathy et al, (2011). HLA-B*35:01 West Australian Keane et al, (2014). HLA-B*35:05 Thai Rash Chantarangsu et al, (2009) HLA-C*04 All cADRs, All Likanonsakul et al, (2009); Carr et al, (2013); Yuan et al, (2011); Gao et al, (2012). HLA-C*08(-B*14) Sardinian, Japanese, West Australian Hepatic, Rash, Eosinophilia Littera et al, (2006); Gatanga et al, (2007); Keane et al (2014).

4 Nevirapine HSR Complex HLA Class I and Class II associations (phenotype & ethnic specific) Role for both CD4+ and CD8+ T cells in NVP HSR (Keane et al, 2014, AIDS). Low positive predictive value, many without any known HLA risk alleles

5 Abacavir van Deurekom et al. Immunogenetics 2015 Aug;67(8):425-36
Illing, et al Nature 486: ; Ostrov et al Proc Natl Acad Sci U S A 109: ; 33; Norcross et al AIDS 26:F21-9

6 Do similarities in the HLA peptide binding groove explain the HLA-diversity in NVP HSR?
Class I. (HLA-A, -B, -C). Pockets A-F van Deurekom et al. Immunogenetics Aug;67(8):425-36 Class II. (HLA-DRB1). Pockets P1, P4, P6, P7, P9 Murthy et al. Structure. 5 (10): (1997)

7 Methods… 5 distinct self-reported ethnicities
Samples Case controlled study of cutanous NVP HSR (n=151 cases, n=413 controls) 5 distinct self-reported ethnicities Asian: South-East Asian and Taiwanese; African: African American Caucasian: European and Hispanic Analysis HLA-A,-B-,-C, -DR typing (4 digit) and CYP2B6 genotyping Univariate and multi-variate logistic regression (adjusted for ethnicity) Alleles, supertypes, predicted peptide binding (MHCcluster), binding pocket residues In silico modelling and molecular docking scores for identified candidates.

8 HLA associations with cutaneous NVP HSR
(b)Protective HLA-B B pocket (B62 alleles) (c)Predisposing HLA-B E pocket (B*35:05) (d)Predisposing HLA-DRB1 P4 pocket (DRB1*01 and 04 alleles)

9 Multivariate modelling was used to examine the overall risk for cutaneous NVP HSR associated with the identified predisposing and protective allele clusters in both whole-cohort and ethnic-specific analysis. Striking similarities in observed relative odds are evident across ancestral groups, despite varying allele frequency distributions.

10 Conclusions Cutaneous NVP HSR associates with HLA-C alleles having similar peptide binding properties and F pocket structure as HLA-C*04:01. Secondary associations with cutaneous NVP HSR are attributable to Class I and II binding pocket structure; A shared P4 pocket groups HLA-DRB1 risk alleles A characteristic B pocket defines a protective cluster of HLA-B alleles NVP HSR provides a model to explain the basis for complex and multi-allelic associations in drug hypersensitivity

11 Future work…. Peptide binding ? TCR
Peptide elution studies with HLA-C*04:01 and DRB1*01:01 SALs TCR sequencing in HLA characterised patient PBMCs, blister fluid & in affected v normal skin. Peptide binding ? TCR Drug - Nevirapine HLA

12 Acknowledgements Elizabeth Phillips Simon Mallal Elizabeth McKinnon
The Institute for Immunology & Infectious Diseases Murdoch University, Perth WA Elizabeth Phillips Simon Mallal Elizabeth McKinnon Abha Chopra Alec Redwood Silvana Gaudieri David Ostrov University of Florida, USA Jing Yuan Boehringer Ingelheim Pharmaceuticals David Haas Vanderbilt University, USA. Bjoern Peters La Jolla Institute for Allergy and Immunology Soren Buus University of Copenhagen David Koelle University of Washington Mary Carrington Ragon Institute of MGH, MIT & Harvard

Download ppt "Specific Binding Characteristics of HLA Alleles Associated with Nevirapine Hypersensitivity Rebecca Pavlos, PhD The Institute for Immunology & Infectious."

Similar presentations

HIV to AIDS Adam Jones. Main Theories THEORY 1 –Began in 1940 in Africa Thought hunters were butchering monkeys that had SIV, a disease with similar characteristic.

HIV to AIDS Adam Jones. Main Theories THEORY 1 –Began in 1940 in Africa Thought hunters were butchering monkeys that had SIV, a disease with similar characteristic.
Initiating Antiretroviral Therapy in Treatment-Naive Patients Charles B. Hicks, MD Associate Professor of Medicine, Division of Infectious Diseases and.

Initiating Antiretroviral Therapy in Treatment-Naive Patients Charles B. Hicks, MD Associate Professor of Medicine, Division of Infectious Diseases and.
“Theoretical and Experimental description of Peptide-MHC binding”

“Theoretical and Experimental description of Peptide-MHC binding”
High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection Abstract.

High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection Abstract.
MHC Polymorphism. MHC Class I pathway Figure by Eric A.J. Reits.

MHC Polymorphism. MHC Class I pathway Figure by Eric A.J. Reits.
Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.

Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.
Institute of Immunology, ZJU

Institute of Immunology, ZJU
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa Paul K. Drain, Elena Losina, Senica Chetty, Gary.

Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa Paul K. Drain, Elena Losina, Senica Chetty, Gary.
Overcoming the Barriers of Clinical Translation: The Abacavir Example Elizabeth J. Phillips, MD, FRCPC, FRACP Professor & Director, Centre for Clinical.

Overcoming the Barriers of Clinical Translation: The Abacavir Example Elizabeth J. Phillips, MD, FRCPC, FRACP Professor & Director, Centre for Clinical.
Washington D.C., USA, 22-27 July 2012www.aids2012.org HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong,

Washington D.C., USA, July 2012www.aids2012.org HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong,
HIV, CD4, and More Karen Hutcherson Jenn Mann Elizabeth McCauley Michael Powers Courtney Wilson.

HIV, CD4, and More Karen Hutcherson Jenn Mann Elizabeth McCauley Michael Powers Courtney Wilson.
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,

Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
Plate 87 Acquired Immune Deficiency Syndrome (AIDS)

Plate 87 Acquired Immune Deficiency Syndrome (AIDS)
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.

The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Effects of HIV-1 Immune Selection on Susceptability to Integrase Inhibitor Resistance Introduction Integrase inhibitors have emerged as an important new.

Effects of HIV-1 Immune Selection on Susceptability to Integrase Inhibitor Resistance Introduction Integrase inhibitors have emerged as an important new.
Www.aids2012.org Washington D.C., USA, JULY 22-27 2012 Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.

Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Overview Pediatric HIV Program & IMPAACT/ PACTG Vaccine Research Children’s National Medical Center, Washington, DC Dr.Hans ML Spiegel Director Special.

Overview Pediatric HIV Program & IMPAACT/ PACTG Vaccine Research Children’s National Medical Center, Washington, DC Dr.Hans ML Spiegel Director Special.
HLA-B*5701 and Abacavir Alec Walker October 2014.

HLA-B*5701 and Abacavir Alec Walker October 2014.
HIV-1 evolution in response to immune selection pressures

HIV-1 evolution in response to immune selection pressures
Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.

Increased clinical events in HIV-infected patients who achieve full virologic suppression but fail to attain a CD4 count ≥ 200 cells/mm 3 after one year.

Similar presentations

Ads by Google